Hsbc Holdings Plc

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 7,632
Total Value: 116002478410
Accession Number: 0000873630-25-000002
Form Type: 13F-HR
CIK: 0000873630
Manager Name: Hsbc Holdings Plc

Data Enrichment

96% identified

7,290 identified342 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

7,632 positions • $116,002,478.41K total value

7,632 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 128 of 128

Sort by:

Adaptimmune Therapeutics PLC

Shares:

26064(+0.0%)

Value:

$5.2M(-63.6%)

OFFICE PROPERTIES INCOME TRUST

Shares:

11080(+0.0%)

Value:

$5.1M(-53.6%)

X4 Pharmaceuticals, Inc

Shares:

19925(+0.9%)

Value:

$4.7M(-70.0%)

Mersana Therapeutics, Inc.

Shares:

12494(-6.1%)

Value:

$4.4M(-76.1%)

LanzaTech Global, Inc.

Shares:

13069(-0.6%)

Value:

$3.7M(-80.3%)

Liberty Latin America Ltd.

LILAK|G9001E128

Shares:

164(+0.0%)

Value:

$1.0M(-2.0%)

Instrument	Shares		Other Manager	Value
Adaptimmune Therapeutics Plc(ADAPcusip00653A107)	26.1K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.2K	QoQ -63.62% (-$9.1K) YoY -87.33% (-$36.0K)
Office Properties Income Trust(OPIcusip67623C109)	11.1K	QoQ 0.00% (-0) YoY -56.44% (-14.4K)	All Managers (Combined)	$5.1K	QoQ -53.57% (-$5.9K) YoY -90.14% (-$46.8K)
X4 Pharmaceuticals, Inc(XFORcusip98420X103)	19.9K	QoQ +0.88% (-174) YoY +41.06% (-5.8K)	All Managers (Combined)	$4.7K	QoQ -70.01% (-$11.0K) YoY -76.07% (-$14.9K)
Mersana Therapeutics, Inc.(MRSNcusip59045L106)	12.5K	QoQ -6.06% (-807) YoY -0.90% (-114)	All Managers (Combined)	$4.4K	QoQ -76.06% (-$13.9K) YoY -92.24% (-$52.1K)
Lanzatech Global, Inc.(LNZAcusip51655R101)	13.1K	QoQ -0.64% (-85) YoY NEW(+13.1K)	All Managers (Combined)	$3.7K	QoQ -80.25% (-$14.9K) YoY NEW(+$3.7K)
Liberty Latin America Ltd.(LILAKcusipG9001E128)	164	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.0K	QoQ -2.01% (-$21) YoY -11.08% (-$127)